1. Home
  2. STAA

as of 02-05-2026 3:54pm EST

$17.05
$0.02
-0.12%
Stocks Health Care Ophthalmic Goods Nasdaq

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Founded: 1982 Country:
United States
United States
Employees: N/A City: MONROVIA
Market Cap: 1.0B IPO Year: N/A
Target Price: $23.53 AVG Volume (30 days): 1.4M
Analyst Decision: Hold Number of Analysts: 12
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.95 EPS Growth: N/A
52 Week Low/High: $13.50 - $30.81 Next Earning Date: 02-17-2026
Revenue: $230,591,000 Revenue Growth: -32.42%
Revenue Growth (this year): -16.35% Revenue Growth (next year): 22.19%
P/E Ratio: N/A Index: N/A
Free Cash Flow: -39542000.0 FCF Growth: N/A

Stock Insider Trading Activity of STAAR Surgical Company (STAA)

STAA Jan 9, 2026

Avg Cost/Share

$11.03

Shares

27,485

Total Value

$606,137.70

Owned After

15,453,629

STAA Jan 8, 2026

Avg Cost/Share

$10.97

Shares

3,240

Total Value

$71,082.04

Owned After

15,453,629

STAA Jan 7, 2026

Avg Cost/Share

$11.00

Shares

66,467

Total Value

$1,462,300.59

Owned After

15,453,629

STAA Jan 6, 2026

Avg Cost/Share

$10.85

Shares

336,946

Total Value

$7,284,281.10

Owned After

15,453,629

SEC Form 4

Share on Social Networks: